Overall, pretty satisfied with the update. Plausible explanations for delays, some foundations being laid through Eversana, reassured that financing is a problem, but solutions seem available.

One gripe: crowing about not budging below .85 for private placements is a joke. How many investors have an average cost at or below that number?? Then flippantly sniping "so if YOU want to sell where the price is right now, have at it!" Zero reason to be snarky about people losing confidence in this investment, or NEEDING TO SELL at these ridiculous prices.